Amplia Therapeutics Ltd (ATX) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.028x

Based on the latest financial reports, Amplia Therapeutics Ltd (ATX) has a cash flow conversion efficiency ratio of -0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.09 Million ≈ $-768.53K USD) by net assets (AU$39.47 Million ≈ $27.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Amplia Therapeutics Ltd (ATX) liquidity interval to measure how many days the company can operate on defensive assets alone.

Amplia Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2010–2026)

This chart illustrates how Amplia Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Amplia Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Amplia Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
AbL Diagnostics SA PA:ABLD	0.063x
TWL Holdings Bhd KLSE:7079	-0.043x
CammSys Corp KQ:050110	-0.060x
Korea Electronic Certification Authority Inc KQ:041460	0.036x
Routon Electronic Co Ltd SHG:600355	0.032x
3I Infrastructure PLC LSE:3IN	-0.006x
Universus Photo Imagings Limited NSE:UNIVPHOTO	0.000x
Samhwa Networks Co. Ltd KQ:046390	0.086x

Annual Cash Flow Conversion Efficiency for Amplia Therapeutics Ltd (2010–2026)

The table below shows the annual cash flow conversion efficiency of Amplia Therapeutics Ltd from 2010 to 2026. For the full company profile with market capitalisation and key ratios, see Amplia Therapeutics Ltd (ATX) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	AU$39.47 Million ≈ $27.93 Million	AU$-8.73 Million ≈ $-6.18 Million	-0.221x	+32.44%
2025-03-31	AU$21.02 Million ≈ $14.88 Million	AU$-6.89 Million ≈ $-4.87 Million	-0.328x	+27.06%
2024-03-31	AU$11.42 Million ≈ $8.08 Million	AU$-5.13 Million ≈ $-3.63 Million	-0.449x	-34.42%
2023-03-31	AU$15.84 Million ≈ $11.20 Million	AU$-5.29 Million ≈ $-3.74 Million	-0.334x	-65.79%
2022-03-31	AU$21.85 Million ≈ $15.46 Million	AU$-4.40 Million ≈ $-3.11 Million	-0.201x	+28.56%
2021-03-31	AU$10.34 Million ≈ $7.32 Million	AU$-2.92 Million ≈ $-2.06 Million	-0.282x	-16.24%
2020-03-31	AU$8.61 Million ≈ $6.09 Million	AU$-2.09 Million ≈ $-1.48 Million	-0.243x	-112.92%
2019-03-31	AU$8.66 Million ≈ $6.13 Million	AU$-987.35K ≈ $-698.61K	-0.114x	+92.41%
2018-03-31	AU$2.36 Million ≈ $1.67 Million	AU$-3.55 Million ≈ $-2.51 Million	-1.501x	-61.48%
2017-03-31	AU$6.63 Million ≈ $4.69 Million	AU$-6.16 Million ≈ $-4.36 Million	-0.930x	+21.06%
2016-03-31	AU$4.00 Million ≈ $2.83 Million	AU$-4.71 Million ≈ $-3.34 Million	-1.178x	-44.06%
2015-03-31	AU$4.87 Million ≈ $3.44 Million	AU$-3.98 Million ≈ $-2.81 Million	-0.817x	-397.85%
2014-03-31	AU$9.77 Million ≈ $6.91 Million	AU$-1.60 Million ≈ $-1.14 Million	-0.164x	-5.13%
2013-03-31	AU$11.23 Million ≈ $7.95 Million	AU$-1.75 Million ≈ $-1.24 Million	-0.156x	+60.77%
2012-03-31	AU$3.19 Million ≈ $2.26 Million	AU$-1.27 Million ≈ $-899.95K	-0.398x	-50.85%
2011-03-31	AU$6.07 Million ≈ $4.30 Million	AU$-1.60 Million ≈ $-1.13 Million	-0.264x	+22.54%
2010-03-31	AU$5.98 Million ≈ $4.23 Million	AU$-2.04 Million ≈ $-1.44 Million	-0.341x	--

About Amplia Therapeutics Ltd

AU:ATX Australia Biotechnology

Market Cap

$41.77 Million

AU$59.03 Million AUD

Market Cap Rank

#22600 Global

#822 in Australia

Share Price

AU$0.12

Change (1 day)

-4.17%

52-Week Range

AU$0.11 - AU$0.36

All Time High

AU$16.20